C O M P A N Y A N N O U N C E M E N T N O . 1 / 2 0 1 3

3 January 2013

Reduction of the share capital of Chr. Hansen Holding A/S completed

At the Annual General Meeting of Chr. Hansen Holding A/S held on Tuesday, 27 November 2012, it was decided to reduce the Company's share capital with nominally DKK 35,342,440 from DKK

1,380,342,200 to DKK 1,344,999,760 by cancellation of 3,534,244 treasury shares of DKK 10 each

acquired under the Company's share buy-back program.

Chr. Hansen Holding

A/S has today registered the

completion of the reduction of

the share

capital with the Danish Business Authority and consequently cancelled nominally DKK 3,534,244 shares. After the reduction of the share capital, the Company's share capital is nominally DKK

1,344,999,760.

For further information, please contact:

Anders Mohr Christensen, Senior Director IR

Tel: +45 4574 7618

Kristine Ahrensbach, Director, Corporate Communications

Tel: +45 4574 7623

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2011/12 financial year was EUR 699 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,450 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen. For further information, please visit www.chr-hansen.com.
Chr. Hansen Holding A/S - Completion of share buy-back program
Chr. Hansen Holding A/S Boege Allé 10-12
DK-2970, Hoersholm
Denmark

Tel. +45 45 74 74 74 www.chr-hansen.com CVR-no: 28318677
Page 1/1

distributed by